Bruckel Jeffrey, Wagle Neil, O'Brien Cashel, Elias Josephine, McKenna Sharon, Meyers Peter, Fifer Michael A, Pomerantsev Eugene, Yeh Robert W
From the *Massachusetts General Hospital, Edward P. Lawrence Center for Quality and Safety, Boston, MA; †University of Rochester Medical Center, Division of Cardiovascular Disease, Rochester, NY; ‡Brigham and Women's Hospital, Division of General Medicine and Primary Care, Boston, MA; §Harvard Medical School; ‖Partners Healthcare System, Boston, MA; and ¶Massachusetts General Hospital, Corrigan-Minehan Heart Center, Boston, MA.
Crit Pathw Cardiol. 2015 Dec;14(4):139-45. doi: 10.1097/HPC.0000000000000058.
Percutaneous coronary intervention is the most commonly performed revascularization modality for chronic stable angina, but does not improve survival or reduce major adverse cardiovascular event. Percutaneous coronary intervention in this population is performed primarily for symptomatic benefit; therefore, symptom reduction is an important marker of quality. Patient-reported outcome measures (PROMs) have been developed for chest pain and dyspnea which are valid and responsive to treatment; however, they are not widely used in routine care. We present a model for use of PROMs in routine care.
Partners Health System funded a tablet computer software platform to collect PROMs and include them in the medical record. We implemented this platform in the catheterization laboratory at Massachusetts General Hospital, targeting patients presenting for coronary angiography. Patients are assessed using the SAQ-7, the Rose dyspnea scale, the PHQ-2, and the PROMIS-10. We used a phased implementation, with the final program including preprocedure measurement, presentation of data to clinical providers, and follow up using an email platform.
We successfully captured measures from 474 patients, 53.5% of outpatient visits. Key success factors included high-level leadership support and resources, a user-friendly interface for patients and staff, easily interpretable measures, and clinical relevance.
We have demonstrated that routine capture of patient-reported symptom severity is technically feasible in a real-world care environment. We share our experiences to provide others with a model for similar programs, and to accelerate implementation nationwide by helping others avoid pitfalls. We believe expansion of similar programs nationally may lead to more robust quality infrastructure.
经皮冠状动脉介入治疗是慢性稳定型心绞痛最常用的血运重建方式,但并不能提高生存率或减少主要不良心血管事件。该人群进行经皮冠状动脉介入治疗主要是为了获得症状改善;因此,症状减轻是质量的重要指标。已开发出针对胸痛和呼吸困难的患者报告结局测量指标(PROMs),这些指标有效且对治疗有反应;然而,它们在常规护理中并未得到广泛应用。我们提出了一种在常规护理中使用PROMs的模式。
合作伙伴医疗系统资助了一个平板电脑软件平台来收集PROMs并将其纳入病历。我们在马萨诸塞州总医院的心导管实验室实施了该平台,目标是接受冠状动脉造影的患者。使用SAQ-7、罗斯呼吸困难量表、PHQ-2和PROMIS-10对患者进行评估。我们采用分阶段实施,最终方案包括术前测量、向临床医生展示数据以及使用电子邮件平台进行随访。
我们成功收集了474例患者的测量数据,占门诊就诊患者的53.5%。关键成功因素包括高层领导的支持和资源、对患者和工作人员友好的界面、易于解释的测量指标以及临床相关性。
我们已经证明,在现实世界的护理环境中,常规收集患者报告的症状严重程度在技术上是可行的。我们分享经验,为其他人提供类似项目的模式,并通过帮助其他人避免陷阱来加速全国范围内的实施。我们相信在全国范围内推广类似项目可能会带来更强大的质量基础设施。